RxDoctor Payments Data

Landon Bowerbank, DPM

Foot & Ankle Surgery · Lehi, UTNPI 1083234975

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Orthofix Medical, Inc. at 36.8% of the total. Reporting peaked in 2022 at $3,474 and has fallen 96.2% since, to $131 in 2025.

$4,545in general payments, 2019–2025

Across 62 payments — averaging $73.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$2K
  • Rock Medical Orthopedics, Inc.$1K
  • Integra Lifesciences Corporation$855
  • Smith+Nephew$310
  • Stryker$191
  • Treace Medical Concepts, Inc.$52
  • plus $250 from 9 others

What the payments were for

  • Travel & lodging$1,39231%
  • Food & beverage$1,78639%
  • Education$1,20026%
  • Other$1674%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,545 in reported general payments places this provider in the 55th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$181,871
Medicare patients
96
Services billed
442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole13$157
Doxycycline Hyclate17$134
Cephalexin11$75

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lehi

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →